Gang Wang

Gang Wang

Auto-generated profile, based on publicly available information

Gang Wang

Late Stage Downstream Process Development Boehringer Ingelheim Pharma GmbH/Co. KG Biberach an der Riss Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in mAbs
Verified
Journal Article
Open access
JWJiarui Wang
Jiarui Wang
JCJingyi Chen
Jingyi Chen
JSJoey Studts
Joey Studts
GWGang Wang
Gang Wang
The implementation of process analytical technologies is positioned to play a critical role in advancing biopharmaceutical manufacturing by simultaneously resolving clinical, regulatory, and cost challenges. Raman spectroscopy is emerging as a key technology enabling in-line product quality monitoring, but laborious calibration and computational modeling efforts limit the widespread application of this promising technology. In this study, we demonstrate new capabilities for measuring product aggregation and fragmentation in real-time during a bioprocess intended for clinical manufacturing by applying hardware automation and machine learning data analysis methods. We reduced the effort needed to calibrate and validate multiple critical quality attribute models by integrating existing workflows into one robotic system. The increased data throughput resulting from this system allowed us to train calibration models that demonstrate accurate product quality measurements every 38 s. In-process analytics enable advanced process understanding in the short-term and will lead ultimately to controlled bioprocesses that can both safeguard and take necessary actions that guarantee consistent product quality.

1 January 2023 in Computers, Materials & Continua
Verified
Journal Article
Open access
PDF file
TLTengda Li
Tengda Li
GWGang Wang
Gang Wang
QFQiang Fu
Qiang Fu
XGXiangke Guo
Xiangke Guo
MZMinRui ZHAO
MinRui ZHAO
XLXiangyu Liu
Xiangyu Liu
Aiming at the problems of traditional dynamic weapon-target assignment algorithms in command decision-making, such as large computational amount, slow solution speed, and low calculation accuracy, combined with deep reinforcement learning theory, an improved Deep Deterministic Policy Gradient algorithm with dual noise and prioritized experience replay is proposed, which uses a double noise mechanism to expand the search range of the action, and introduces a priority experience playback mechanism to effectively achieve data utilization. Finally, the algorithm is simulated and validated on the ground-to-air countermeasures digital battlefield. The results of the experiment show that, under the framework of the deep neural network for intelligent weapon-target assignment proposed in this paper, compared to the traditional RELU algorithm, the agent trained with reinforcement learning algorithms, such as Deep Deterministic Policy Gradient algorithm, Asynchronous Advantage Actor-Critic algorithm, Deep Q Network algorithm performs better. It shows that the use of deep reinforcement learning algorithms to solve the weapon-target assignment problem in the field of air defense operations is scientific. In contrast to other reinforcement learning algorithms, the agent trained by the improved Deep Deterministic Policy Gradient algorithm has a higher win rate and reward in confrontation, and the use of weapon resources is more efficient. It shows that the model and algorithm have certain superiority and rationality. The results of this paper provide new ideas for solving the problem of weapon-target assignment in air defense combat command decisions.

28 February 2024 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
JWJiarui Wang
Jiarui Wang
JCJingyi Chen
Jingyi Chen
JSJoey Studts
Joey Studts
GWGang Wang
Gang Wang
Several key technologies for advancing biopharmaceutical manufacturing depend on the successful implementation of process analytical technologies that can monitor multiple product quality attributes in a continuous in‐line setting. Raman spectroscopy is an emerging technology in the biopharma industry that promises to fit this strategic need, yet its application is not widespread due to limited success for predicting a meaningful number of quality attributes. In this study, we addressed this very problem by demonstrating new capabilities for preprocessing Raman spectra using a series of Butterworth filters. The resulting increase in the number of spectral features is paired with a machine learning algorithm and laboratory automation hardware to drive the automated collection and training of a calibration model that allows for the prediction of 16 different product quality attributes in an in‐line mode. The demonstrated ability to generate these Raman‐based models for in‐process product quality monitoring is the breakthrough to increase process understanding by delivering product quality data in a continuous manner. The implementation of this multiattribute in‐line technology will create new workflows within process development, characterization, validation, and control.